Neurocrine Biosciences Shows Rising Price Performance With Jump To 81 RS Rating

By Investor's Business Daily | Jul 25, 2024 at 03:00 AM EST

Learn how to find the best IPO stocks with IBD's RS Rating, tracking market leadership by comparing a stock's price action to others. Stocks with an RS Rating over 80 tend to perform well. Neurocrine Biosciences is currently in a buy range after climbing above an entry point.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.